Evidence map›Paper›PMID 40104699›Full record

ReviewTranslational cancer research2025

The emerging role of transmembrane proteins in tumorigenesis and therapy.

Chenlu Shen, Xiao Han, Qi Liu, Tao Lu, Weiwei Wang, Xinyi Wang, Zhimin Ou, Shengjie Zhang, Xiangdong Cheng

Abstract readReview
In one paragraph

Review in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chenlu Shen *College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.
Xiao Han *Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Qi LiuDepartment of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Tao LuDepartment of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Weiwei WangDepartment of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Xinyi WangDepartment of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Zhimin OuCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.
Shengjie ZhangDepartment of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, China.ORCID https://orcid.org/0000-0002-6250-4752
Xiangdong ChengDepartment of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou, China.ORCID https://orcid.org/0000-0002-5099-490X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transmembrane proteins (TMEMs) are a kind of proteins that can cross the phospholipid bilayer one or multiple times and remain permanently anchored. They are involved in the regulation of many biological functions, and their dysregulation is associated with many human diseases and even cancer. Abnormal expression alterations of TMEMs widely exist in tumor tissues compared with paracancerous tissues. They are associated with the clinicopathological features of cancer patients by promoting or inhibiting the development of cancer, thus affecting survival. This review summarized the structure and physiological functions of TMEMs, as well as their roles in tumorigenesis, such as cell proliferation, apoptosis, autophagy, adhesion, metastasis, metabolism and drug resistance. In addition, we elaborated on the potentiality of TMEMs for tumor immunity. Moreover, the advances of TMEMs were subsequently retrospected in several common types of human cancers, including breast cancer, gastric cancer, and lung cancer. Subsequently, we outlined the targeted therapeutic strategies against TMEMs proposed based on existing studies. To date, there are still many TMEMs whose functions and mechanisms have not been well known due to their special structures. Since the important roles TMEMs plays in the development of human cancers, it is urgent to portray their structure and function in carcinogenesis, providing potential biomarkers for cancer patients in the future.

Indexed as

drug resistancemetabolismTransmembrane proteins (TMEMs)tumorigenesistumor immunity

Identifiers

PMID40104699
PMCPMC11912080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.